en · de · es · fr · pt
analytical-notes.peptides9002.com › News › Chemistry And Receptor Pharmacology — What the Evidence Shows

Chemistry And Receptor Pharmacology — What the Evidence Shows

By Editorial Desk · published 2026-07-12 · last reviewed 2026-08-01 · News

Melanotan II comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.

Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.

Chemistry and Receptor Pharmacology

Receptor-binding studies classify melanotan II as a non-selective melanocortin agonist. It interacts with MC1R, MC3R, MC4R and MC5R, with reported affinities in the low nanomolar range and no strong subtype preference. Activation of MC1R on dermal melanocytes shifts pigment synthesis toward eumelanin, the dark polymer deposited in melanosomes and transferred to keratinocytes. Because the same peptide engages MC4R in the hypothalamus, it also appears in animal work on food intake and erectile response, which is why it is discussed in both pigment and metabolic research. Which receptor populations dominate after systemic exposure in humans is not fully established.

Published pharmacokinetic information is limited and comes mainly from small studies rather than registrational trials. Plasma half-life is usually described as short, on the order of tens of minutes, followed by rapid tissue distribution and clearance of the intact peptide. Metabolites and low concentrations of parent compound have been reported in urine, a detail relevant to anti-doping and forensic testing. Whether repeated exposure changes receptor sensitivity or clearance over time remains an open question. Values differ noticeably between analytical assays, so published numbers should be read as approximate rather than definitive.

Melanotan-2 Identity And Regulatory Status

Regulatory treatment varies between countries. Several national medicines agencies have classified the peptide as unapproved, and customs authorities in some jurisdictions seize shipments on that basis. A few jurisdictions channel supply through prescription-only frameworks that do not list the substance by name. Because the material circulates mainly through online vendors, composition and purity are rarely verified before sale. Surveys of unapproved peptide products have reported labels that did not match measured content in a substantial fraction of samples.

Melanotan II is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its structure substitutes a lactam bridge between side chains to increase stability relative to the native hormone. The compound is also known by the shorthand MT-II and by several non-proprietary synonyms used in research catalogues. It is not an approved therapeutic product in any major jurisdiction; material sold under this name is typically offered as a laboratory reagent rather than as a medicine.

Activity is attributed to agonism at melanocortin receptors, particularly MC1R and MC4R. Activation of MC1R on melanocytes increases melanin synthesis, which underlies the reported tanning effect. MC4R engagement in the central nervous system is linked to appetite suppression and to effects on sexual arousal reported in early clinical studies. Those studies were small and were not designed to establish efficacy or long-term safety. Receptor selectivity among the melanocortin subtypes is not absolute, which complicates attribution of any effect to a single pathway.

Melanotan-2 at a glance

PropertyValueNotes
Molecular formulaC50H69N15O9Cyclic heptapeptide, C-terminally amidated
Approximate molecular mass1024 DaMonoisotopic mass of the free peptide
AppearanceWhite to off-white powderTypically supplied as a lyophilised solid
Solubility classSoluble in water and polar solventsAlso dissolves in neutral aqueous buffer
Common synonymsMelanotan II, MT-II, MT-2Described as a melanocortin agonist in early literature

Identity and Chemical Background

The compound emerged from research programs in the 1980s that examined analogues of alpha-melanocyte-stimulating hormone for pigmentation and photoprotection. Investigators modified the native sequence to extend activity duration and potency. A related analogue, afamelanotide, was developed within the same broad line of inquiry and eventually gained approval in certain jurisdictions for a rare light-sensitivity condition. Melanotan-2 itself did not progress through the same regulatory route and has no approved therapeutic indication.

Melanocortin receptors comprise five subtypes with distinct tissue distributions and functions. Melanotan-2 is described in the literature as a non-selective agonist that engages several of these subtypes, including MC1R, MC3R, MC4R, and MC5R. MC1R is the subtype most directly linked to melanin production in skin cells. Because the compound is not subtype-selective, its observed effects in experimental settings are generally attributed to activity across multiple receptor pathways rather than to a single target.

Related pages on this site

Peptide Identity and Structural Background

Structurally, Melanotan-2 retains the core recognition motif of alpha-melanocyte-stimulating hormone while adding a lactam bridge that links two side chains and constrains the molecule into a ring. This modification lowers susceptibility to enzymatic degradation. The compound acts as an agonist at melanocortin receptors, particularly subtypes associated with melanin production. Because the same receptor family influences several physiological processes, researchers note that its activity is not confined to pigmentation alone. Receptor selectivity continues to be examined in published studies.

Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its sequence incorporates modified residues that increase potency and extend biological activity relative to the native hormone. The compound binds receptors of the melanocortin family and is examined mainly in laboratory research. It does not occur naturally and exists only as a manufactured chemical entity produced by solid-phase synthesis.

Reference notes

== Animal studies == Evidence for an effect of AVP on monogamy vs polygamy comes from experimental studies in several species, which indicate that the precise distribution of vasopressin and vasopressin receptors in the brain is associated with species-typical patterns of social behavior. In particular, there are consistent differences between monogamous species and polygamous species in the distribution of AVP receptors, and sometimes in the distribution of vasopressin-containing axons, even when closely related species are compared.

In early December 2025, Colombian president Petro's personal lawyer filed a complaint with the Inter-American Commission on Human Rights (IACHR) against Hegseth on behalf of Carranza's family. According to CNN, the sister of the Ecuadorian survivor of the 16 October strike, repatriated to Ecuador, "claim[ed] to know nothing of her brother's alleged involvement with drug trafficking and instead portrayed him as a desperate father trying to provide for his six kids". The Ecuadorian had been convicted and deported from the US in 2020 for drug smuggling. The Ecuadorian attorney general's office stated that no crime reports had been filed against him with their institution, so absent evidence for detaining him, the subject was released. The other survivor of the 16 October strike, repatriated to Colombia, was hospitalized upon arrival with moderate injuries, including a skull fracture. Petro and Armando Benedetti, Colombian Minister of the Interior, said at the time he was repatriated the survivor would be "prosecuted according to the law, because he is allegedly a criminal who was trafficking drugs". However, because the incident occurred in international waters, outside Colombian territory, he would only be prosecuted if he voluntarily spoke and incriminated himself. He was released on 6 November with no charges.

where 44.02621 is the calculated IUPAC mass for C2H4O. Alternatively, a KMD plot can be constructed for the same copolymer by using propylene oxide as the base unit. Polymer mass spectra containing multiple charge ions exhibit isotopic splitting.

After Reagan's military buildup, the Soviet Union did not respond by further building its military, because the enormous military expenses, along with inefficient planned manufacturing and collectivized agriculture, were already a heavy burden for the Soviet economy. At the same time, Saudi Arabia increased oil production, even as other non-OPEC nations were increasing production. These developments contributed to the 1980s oil glut, which affected the Soviet Union as oil was the main source of Soviet export revenues. Issues with command economics, oil price decreases and large military expenditures gradually brought the Soviet economy to stagnation.

Human oocyte cryopreservation is a new technology in which a woman's eggs (oocytes) are extracted, frozen and stored. Later, when she is ready to become pregnant, the eggs can be thawed, fertilized, and transferred to the uterus as embryos. Since 1999, when the birth of the first baby from an embryo-derived from vitrified-warmed woman's eggs was reported by Kuleshova and co-workers in the journal of Human Reproduction, this concept has been recognized and widespread. This breakthrough in achieving vitrification of a woman's oocytes made an important advance in our knowledge and practice of the IVF process, as the clinical pregnancy rate is four times higher after oocyte vitrification than after slow freezing. Oocyte vitrification is vital for preserving fertility in young oncology patients and for individuals undergoing IVF who object, for either religious or ethical reasons, to the practice of freezing embryos.

Sources: en.wikipedia.org

Reference notes

=== Citizens' band and personal radio services === Citizens' band radio is allocated in many countries, using channelized radios in the upper HF part of the spectrum (around 27 MHz). It is used for personal, small business and hobby purposes. Other frequency allocations are used for similar services in different jurisdictions, for example UHF CB is allocated in Australia. A wide range of personal radio services exist around the world, usually emphasizing short-range communication between individuals or for small businesses, simplified license requirements or in some countries covered by a class license, and usually FM transceivers using around 1 watt or less.

proteoglycan Any heavily glycosylated protein, i.e. a core polypeptide with one or more covalently attached glycosaminoglycan chains. Proteoglycans are therefore considered a subclass of glycoproteins in which the carbohydrate units are long, linear polysaccharide polymers containing amino sugars and generally bearing a net negative charge under physiological conditions due to the presence of sulfates and uronic acid groups. They are a major component of the extracellular matrix between animal cells, where they form large hydrated complexes commonly employed in connective tissues such as cartilage.

Zverev's next breakthrough came during the grass court season at the Halle Open, where he upset world No. 3 Roger Federer in the semifinals, ending Federer's streak of ten consecutive appearances in the final while competing at the tournament. He was also the first teenager to defeat Federer since Murray nearly a decade earlier. Nonetheless, he finished runner-up at the event to veteran compatriot Florian Mayer. After this final, he entered the top 30 for the first time and stayed ranked in the 20s for the rest of the season. Despite being seeded at a major tournament for the first time, Zverev could then only match his best major singles result at Wimbledon, again falling to Berdych. During the US Open Series, he reached the semifinals of the Washington Open, but lost his opening round matches at both Masters events. He was then upset in the second round of the US Open by Dan Evans. After the US Open, Zverev returned to Europe and won his first career ATP title at the St. Petersburg Open. He recorded his first win over No. 9 Berdych in the semifinals, and No. 3 Stan Wawrinka in the final, coming back from 0–3 down in the third set. At his next event, he then defeated No. 10 Thiem in the first round of the 2016 China Open for the first time in four tries this year. In doing so, Zverev became the first teenager to record three consecutive victories against top ten opponents since Boris Becker in 1986. Zverev's third round appearance at the Shanghai Masters then helped him rise to No.

During the remainder of the war, Cossack units were dismounted to fight in trenches, held in reserve to exploit a rare breakthrough, or assigned various duties in the rear. Those duties included rounding up deserters, providing escorts to war prisoners, and razing villages and farms in accordance with Russia's scorched earth policy.

Sources: en.wikipedia.org

Frequently asked questions

Is melanotan II identical to alpha-melanocyte-stimulating hormone?

No. It is a synthetic analogue carrying four amino acid changes, a lactam ring and an amidated C-terminus. The natural hormone is a linear thirteen-amino-acid peptide processed from proopiomelanocortin.

How does melanotan II differ from afamelanotide?

Afamelanotide is the linear analogue [Nle4-D-Phe7]-alpha-MSH, sometimes called melanotan I, while melanotan II is cyclic and carries three further substitutions. The two are distinct molecules and are not interchangeable in analytical testing.

Is the receptor binding profile well established?

Binding to the four melanocortin receptor subtypes is well documented in vitro. The relative contribution of each subtype to whole-body effects in humans is far less certain.

Is melanotan II approved for medical use?

No. No major regulatory agency has granted a marketing authorisation for melanotan II as a medicine. Products sold under this name are generally presented as laboratory reagents and are not subject to the batch-release testing applied to approved drugs.

Network